BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies
about
Recent advances in treatment of severe primary immunodeficiencies'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionDisseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.Primary immune deficiencies - principles of care.Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.Vaccinations in paediatric rheumatology: an update on current developments.Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran.Successful treatment of disseminated BCG in a patient with severe combined immunodeficiency.Disseminated BCG Infectious Disease and Hyperferritinemia in a Patient With a Novel NEMO Mutation.CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010-2013).Newborn screening for SCID: lessons learned.Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders.Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined Immunodeficiency.Disseminated papular lesions as a unique manifestation heralding bacille Calmette-Guérin infection in a patient with T-B+NK- severe combined immunodeficiency.Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.Molecular Characteristics, Clinical and Immunologic Manifestations of 11 Children with Omenn Syndrome in East Slavs (Russia, Belarus, Ukraine).Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital.Clinical and Genotypic Spectrum of Chronic Granulomatous Disease in 71 Latin American Patients: First Report from the LASID Registry.Clinical Features, Non-Infectious Manifestations and Survival Analysis of 161 Children with Primary Immunodeficiency in Mexico: A Single Center Experience Over two Decades.Severe combined immunodeficiency syndrome presenting with disseminated BCG infection.BCG-induced Disseminated Mycobacterial Infection of Skin and Bone in an Otherwise Immunocompetent Child.Severe combined immunodeficiencies and related disorders.Vaccine responses in newborns.In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice.Successful Myeloablative Bone Marrow Transplantation in an Infant With Wiskott-Aldrich Syndrome and Bacillus Calmette-Guerin Infection.Idiopathic disseminated bacillus Calmette-Guerin infection in three infants.An infant with ZAP-70 deficiency with disseminated mycobacterial disease.Bacille Calmette–Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010–2017.
P2860
Q26766170-9D2E5B8A-16DD-4B8E-8E0D-C84FF6822516Q28070339-1E26BA4F-78A3-416E-885E-E8EA065D98D0Q33644917-AC7379ED-B4D7-4AD8-995A-7B3C7F80C355Q34423996-D08E240E-9FDA-4150-9EEA-F72D258A3108Q34700023-73D3F918-D96D-492F-B2BB-073774FD27EBQ35510477-94CA1F62-F989-4C57-A0C2-FBD7C185FCBCQ35666223-C05BE91D-1322-4638-9A98-4760D17A0715Q35916231-560471E3-1C58-4571-BC6B-09F2ADC062D9Q36542672-DA7C45CA-6835-4187-8979-8C2374A0F15FQ36628884-7C59D83C-5B44-4EED-B26F-A4DDA3FE74AFQ37287975-D7AAB029-5476-4469-B031-880672726A4FQ37395397-AB3F8C4B-31AF-4397-92D0-F590435EC21CQ38283208-8FE89B3B-EDDA-4888-9A21-AC576E801AECQ38591227-FA979388-D209-442F-815B-AE007203A507Q38824037-E4F49807-745E-4295-A0FA-E08E0F87006DQ39100204-75B3E2E7-1998-456F-BC75-109BEB58149BQ40044232-A610E67C-74B3-4C2E-8630-C6C29CB33AC3Q40118078-7084DE03-670D-4CAC-A0AB-88CFB8DF4E99Q40179148-22C464C3-335C-498E-91B7-F89A06973657Q40278311-D45D373F-EA6A-4CC5-AC69-CF8B777C70B8Q40286856-8EF356BE-FBB8-43AE-B8C7-9EECB080BBEDQ40396576-CD150A07-E8AB-4AA2-8A40-99A1B14B60B7Q40517818-A9DD7E35-2664-46E2-B05D-993D85724C5DQ40725842-F8BF45C6-4BF5-4105-AF5C-32C9E810ED62Q40856019-D7F78975-1FCF-473F-B3B8-41EDEF0F3086Q41130037-2A969420-58C9-410C-9416-08D2163485C6Q41928048-D86BF24C-807A-472D-AA8C-C25B0C3E6E66Q45886049-59244C96-2BDF-4984-AA0A-286C55AB8E87Q46301580-E2718CA2-44CA-4EFD-8DE1-643240F68180Q49359673-4E1CE5D3-1548-47FC-B98E-8558103EB2ACQ50129000-502BD6FA-73F0-4AD1-B7A3-931BDDCAD21CQ50249835-F362A762-DA83-4DE5-AD5C-BF64606C93A5Q50581901-2F2FA49D-BF15-4C74-BBCE-29B86A9813B9Q52938698-B6382AA1-C886-4896-8956-F66101F8023DQ54226001-EADABA78-66E6-47C4-AAE7-3FCDE30C7DEEQ55514852-78BE66F4-C450-4EE8-8631-01C0EB77AD5F
P2860
BCG vaccination in patients with severe combined immunodeficiency: complications, risks, and vaccination policies
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BCG vaccination in patients wi ...... isks, and vaccination policies
@ast
BCG vaccination in patients wi ...... isks, and vaccination policies
@en
BCG vaccination in patients wi ...... sks, and vaccination policies.
@nl
type
label
BCG vaccination in patients wi ...... isks, and vaccination policies
@ast
BCG vaccination in patients wi ...... isks, and vaccination policies
@en
BCG vaccination in patients wi ...... sks, and vaccination policies.
@nl
prefLabel
BCG vaccination in patients wi ...... isks, and vaccination policies
@ast
BCG vaccination in patients wi ...... isks, and vaccination policies
@en
BCG vaccination in patients wi ...... sks, and vaccination policies.
@nl
P2093
P2860
P50
P1476
BCG vaccination in patients wi ...... isks, and vaccination policies
@en
P2093
Alisan Yildiran
Andrea C Gómez Raccio
Andrew Gennery
Anna Shcherbina
Anna Szaflarska
Aydan Ikinciogullari
Beatriz Costa Carvalho
Beatriz E Marciano
Bénédicte Neven
Carlos Torres-Lozano
P2860
P304
P356
10.1016/J.JACI.2014.02.028
P407
P577
2014-04-01T00:00:00Z